Facebook Instagram Twitter Youtube
Tuesday, December 12, 2023
Facebook Instagram Twitter Youtube
Home Merck to launch antiviral pill, Molnupiravir, for Covid Merck to launch antiviral pill, Molnupiravir, for Covid

Merck to launch antiviral pill, Molnupiravir, for Covid

Merck, pill, Molnupiravir, Covid, vaccines, FDA, benefits, anti-vaxers, vaccinated, unvaccinated, Dr Robert Schafer, Jeff Zients,

Clinical trials on a new antiviral drug, Molnupiravir, from Merck were stopped early because the results were so convincing and represent a game-changer for many people worldwide who cannot have, or don’t want, the current vaccines.

Chris Woollams Health Watch is an evidence-based, information-only website. We produce short synopses of the latest research in easy-to-understand language. We do NOT answer questions about individual illnesses. However, you can leave comments about the website. Importantly, people with cancer should go to www.canceractive.com People with cancer may apply to be 'buddied' by Chris Woollams in a Personal Prescription
Contact us: [email protected]
Facebook Instagram Twitter Youtube

Trending News

© Copyright 2021 Chris Woollams Health Watch.